NeuroMetrix, Inc. Officers Interviewed on Plans for Diabetes Market

WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes reported today that in separate interviews Chief Executive Officer, Shai N. Gozani, M.D., Ph.D., and Thomas T. Higgins, Chief Financial Officer, discussed milestones, product plans, and finances for 2012. The interview of Dr. Gozani is on GLX TV, a financial news network, at: http://www.youtube.com/watch?v=NvRKA5SLYuo&feature=youtu.be

Back to news